logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASCO 2020 – Gene-engineered T-cell therapy is safe, partially effective in epithelial cancers

Small phase 1 trial with 12 patients also shows promise in nonhematological malignancies.